Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Repligen: 4Q Earnings Snapshot

02/24/2021 | 07:56am EDT

WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Wednesday reported fourth-quarter profit of $19.7 million.

On a per-share basis, the Waltham, Massachusetts-based company said it had profit of 36 cents. Earnings, adjusted for one-time gains and costs, were 52 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 31 cents per share.

The drug developer posted revenue of $108.6 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $93.9 million.

For the year, the company reported profit of $59.9 million, or $1.11 per share. Revenue was reported as $366.3 million.

Repligen expects full-year earnings in the range of $1.86 to $1.94 per share, with revenue in the range of $500 million to $525 million.

Repligen shares have climbed almost 8% since the beginning of the year. The stock has more than doubled in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGEN at https://www.zacks.com/ap/RGEN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about REPLIGEN CORPORATION
05/05REPLIGENá : HC Wainwright Adjusts Repligen's Price Target to $240 From $225, Mai..
MT
05/04REPLIGENá : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
05/04REPLIGENá : Posts Rise in Q1 Adjusted Profit, Revenue; Amends 2021 Forecasts
MT
05/04REPLIGENá : Reported revenue was $142.8 million for the quarter, representing ye..
PU
05/04REPLIGEN CORPá : Results of Operations and Financial Condition, Financial Statem..
AQ
05/04REPLIGEN : Q1 Earnings Snapshot
AQ
05/04REPLIGENá : Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $142.8M,..
MT
05/04REPLIGENá : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q1 EPS $0.68, vs...
MT
05/04Repligen Reports First Quarter 2021 Financial Resultsáand Updates Full Year 2..
GL
04/20Repligen to Report First Quarter 2021 Financial Results
GL
More news
Financials (USD)
Sales 2021 585 M - -
Net income 2021 97,5 M - -
Net cash 2021 596 M - -
P/E ratio 2021 101x
Yield 2021 -
Capitalization 9 422 M 9 422 M -
EV / Sales 2021 15,1x
EV / Sales 2022 12,6x
Nbr of Employees -
Free-Float 92,9%
Chart REPLIGEN CORPORATION
Duration : Period :
Repligen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REPLIGEN CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 240,25 $
Last Close Price 171,60 $
Spread / Highest target 46,3%
Spread / Average Target 40,0%
Spread / Lowest Target 16,6%
EPS Revisions
Managers and Directors
NameTitle
Tony J. Hunt President, Chief Executive Officer & Director
Jon K. Snodgres Chief Financial Officer
Karen T. Dawes Chairman
Ralf Kuriyel Senior Vice President-Research & Development
James R. Bylund Senior Vice President-Global Operations & IT
Sector and Competitors
1st jan.Capitalization (M$)
REPLIGEN CORPORATION-10.45%9 422
ABBOTT LABORATORIES8.13%206 733
MEDTRONIC PLC6.90%165 975
BECTON, DICKINSON AND COMPANY-3.43%70 273
ALIGN TECHNOLOGY, INC.2.67%43 417
HOYA CORPORATION-9.74%43 396